<p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

Published:2019-11 Issue: Volume:Volume 12 Page:3113-3126
ISSN:1178-7090
Container-title:Journal of Pain Research
language:en
Short-container-title:JPR

Author:

Bergese Sergio D^ORCID,Brzezinski Marek^ORCID,Hammer Gregory B^ORCID,Beard Timothy L,Pan Peter H,Mace Sharon E,Berkowitz Richard D,Cochrane Kristina,Wase Linda^ORCID,Minkowitz Harold S^ORCID,Habib Ashraf

Publisher

Informa UK Limited

Subject

Anesthesiology and Pain Medicine

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aniquinazoline B, a Fungal Natural Product, Activates the μ‐Opioid Receptor;ChemMedChem;2024-07-15

2. Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review;Pharmaceuticals;2023-12-25

3. Pharmacokinetics, pharmacodynamics and safety of LPM3480392 in two phase I clinical trials in healthy Chinese male subjects;Basic & Clinical Pharmacology & Toxicology;2023-09-07

4. Assessment of the potential of novel and classical opioids to induce respiratory depression in mice;British Journal of Pharmacology;2023-08-22

5. Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?;International Journal of Molecular Sciences;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP